Clinitech Laboratory Ltd (CTLLAB) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Clinitech Laboratory Ltd reported sales of ₹4.41 Cr, operating profit of ₹0.45 Cr (OPM 10.2%) and net profit of ₹0.12 Cr for the quarter ended Mar 2026. Figures in ₹ crore, consolidated where available.
CTLLAB quarterly results (₹ Cr) Metric Mar 2025 Sep 2025 Mar 2026 Sales 4.16 5.08 4.41 Expenses 3.88 4.54 3.96 Operating Profit 0.28 0.54 0.45 OPM 6.73% 10.63% 10.2% Other Income 0.17 0.11 0.08 Interest 0.02 0.05 0.02 Depreciation 0.14 0.25 0.26 Profit before tax 0.29 0.35 0.25 Tax 41.38% 14.29% 52% Net Profit 0.17 0.3 0.12 EPS in Rs 0.74 1.31 0.53
CTLLAB profit & loss, annual (₹ Cr) Metric Mar 2025 Mar 2026 Sales 8.23 9.49 Expenses 7.4 8.5 Operating Profit 0.83 0.99 OPM 10.09% 10.43% Other Income 0.23 0.19 Interest 0.06 0.07 Depreciation 0.45 0.51 Profit before tax 0.55 0.6 Tax 29.09% 30% Net Profit 0.39 0.42 EPS in Rs 1.71 1.84 Dividend Payout 0% 0%
CTLLAB balance sheet (₹ Cr) Metric Mar 2025 Mar 2026 Equity Capital 2.28 2.28 Reserves 6.55 6.97 Borrowings 0 0.54 Other Liabilities 2.01 1.38 Total Liabilities 10.84 11.17 Fixed Assets 2.12 2.18 CWIP 1.01 1.25 Investments 0.07 0.07 Other Assets 7.64 7.67 Total Assets 10.84 11.17
CTLLAB cash flows (₹ Cr) Metric Mar 2025 Mar 2026 Cash from Operating Activity -0.88 -0.79 Cash from Investing Activity -0.73 -0.68 Cash from Financing Activity 3.98 0.51 Net Cash Flow 2.37 -0.96 Free Cash Flow -1.73 -1.6 CFO/OP -87% -59%
CTLLAB ratios Metric Mar 2025 Mar 2026 Debtor Days 68.3 71.15 Inventory Days 124.01 117.9 Days Payable 177.82 77.52 Cash Conversion Cycle 68.3 71.15 Working Capital Days 114.42 158.85 ROCE - 7.2%